kwic
identified
identified
right
off
ON
159
1
100
500
strict
ELIZA cgi-bash version rev. 1.91
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for identified out of >500 occurrences
324223 occurrences (No.64 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to identified]
324223 occurrences (No.64 in the rank) during 5 years in the PubMed. [cache]
| 159) The objective of this scoping review is to synthesize available information pertaining to the developmental outcomes of individuals with pathogenic variants in ten emerging recurrent NDD-associated genes identified from large scale sequencing studies; ADNP, ANKRD11, ARID1B, CHD2, CHD8, CTNNB1, DDX3X, DYRK1A, SCN2A, and SYNGAP1. |
| PMID:33179249 DOI:10.1111/cge.13882 |
| 2021 Clinical genetics |
| * Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: A scoping review. |
| - Neurodevelopmental disorders (NDDs) are a heterogeneous group of conditions including intellectual disability, global developmental delay, autism spectrum disorder, and attention deficit hyperactivity disorder. Advances in genetic diagnostic technology have led to the identification of a number of NDD-associated genes, but reports of cognitive and developmental outcomes in affected individuals have been variable. The objective of this scoping review is to synthesize available information pertaining to the developmental outcomes of individuals with pathogenic variants in ten emerging recurrent NDD-associated genes identified from large scale sequencing studies; ADNP, ANKRD11, ARID1B, CHD2, CHD8, CTNNB1, DDX3X, DYRK1A, SCN2A, and SYNGAP1. After a comprehensive search, 260 articles were selected that reported on neurodevelopmental measures or diagnoses. We identify the spectrum of developmental outcomes for each genetic NDD, including prevalence of intellectual disability, frequency of co-morbid NDDs such as ADHD and autism, and commonly reported medical issues that can help inform diagnosis and treatment. There are significant gaps in our understanding of the natural history of these conditions. Future research focusing on barriers to assessment, the development of modified assessment tools appropriate for long-term outcomes in genetic NDD, and collection of longitudinal data will increase understanding of prognosis in these conditions and inform evaluations of treatment. |
[
right
kwic]
| (1)32 *null* | (15)6  several |
(29)2 (1) |
(43)2 eleven |
| (2)31 in |
(16)6 studies |
(30)2 10 |
(44)2 factors |
| (3)27 a |
(17)5 were |
(31)2 17 |
(45)2 key |
| (4)26 as |
(18)4 five |
(32)2 21 |
(46)2 knowledge |
| (5)22 and |
(19)4 practices |
(33)2 22 |
(47)2 many |
| (6)14 the |
(20)3 (a) |
(34)2 23 |
(48)2 more |
| (7)13 from |
(21)3 15 |
(35)2 26 |
(49)2 only |
| (8)10 through |
(22)3 28 |
(36)2 37 |
(50)2 peer-reviewed |
| (9)8 that |
(23)3 an |
(37)2 38 |
(51)2 proteins |
| (10)7 with |
(24)3 including |
(38)2 across |
(52)2 sPLA2-IIA |
| (11)6 by |
(25)3 to |
(39)2 among |
(53)2 significant |
| (12)6 for |
(26)3 using |
(40)2 barriers |
(54)2 three |
| (13)6 four |
(27)3 via |
(41)2 challenges |
|
| (14)6 of |
(28)3 which |
(42)2 during |
add keyword
--- WordNet output for identified ---